PMID: 7028921Aug 1, 1981Paper

Effects of timolol and atenolol on benign essential tremor: placebo-controlled studies based on quantitative tremor recording

Journal of Neurology, Neurosurgery, and Psychiatry
P Dietrichson, E Espen

Abstract

Two different beta-adrenoreceptor antagonists, atenolol and timolol, were separately compared with a placebo in the suppression of essential tremor. In two-week single-blind placebo-controlled studies with cross-over, timolol (5 mg twice daily) and atenolol (100 mg once daily) produced an equal reduction in sitting heart rate and sitting blood pressure. Timolol was effective in reducing tremor while atenolol failed to reduce tremor amplitude. These results indicate that essential tremor can be reduced but not blocked, by the adrenergic blocker timolol with both beta 1 and beta 2 blocking properties; but not by the relatively selective beta 1 blocking drug atenolol. Possibly, the tremor reduction is medicated by a peripheral effect on beta 2 adrenoreceptors.

References

Aug 21, 1976·British Medical Journal·J S Vilsvik, J Schaanning
Jan 1, 1979·Journal of Cardiovascular Pharmacology·P A van Zwieten, P B Timmermans
Aug 9, 1979·The New England Journal of Medicine·C W Britt, B H Peters
Sep 20, 1979·The New England Journal of Medicine·T Riley, A B Pleet
Nov 1, 1979·The New England Journal of Medicine·O Ljung
Sep 1, 1979·Journal of Neurology, Neurosurgery, and Psychiatry·D JeffersonC D Marsden
Oct 1, 1979·Journal of Neurology, Neurosurgery, and Psychiatry·D JeffersonC D Marsden
Nov 6, 1975·The New England Journal of Medicine·R R YoungB T Shahani
Nov 1, 1975·Neurology·E S Tolosa, R B Loewenson
Feb 12, 1972·The Medical Journal of Australia·B S GilliganJ Wodak
Jan 12, 1980·Lancet·D M Turnbull, D A Shaw
Feb 23, 1980·Lancet·D Jefferson, C D Marsden
Sep 1, 1980·Archives of Neurology·R P Newman, L Jacobs

❮ Previous
Next ❯

Citations

Aug 1, 1989·Journal of the Neurological Sciences·M J FillyawM Witarsa
Apr 14, 1984·Lancet·G M Aronoff
Sep 22, 2001·The New England Journal of Medicine·E D Louis
Dec 11, 2008·Psychiatry and Clinical Neurosciences·Beatriz ArbaizarJavier Llorca
Aug 1, 1983·Journal of Neurology, Neurosurgery, and Psychiatry·P N LeighC D Marsden
Dec 14, 2005·Postgraduate Medical Journal·R Bhidayasiri
Mar 10, 2006·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Jack J Chen, Kelly C Lee
May 9, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kelly E LyonsRay L Watts
Oct 4, 2003·Pharmacotherapy·Jack J Chen, David M Swope
Dec 1, 1987·British Journal of Clinical Pharmacology·D JeffersonJ M Patrick
Aug 2, 2003·The American Journal of Medicine·Rajesh Pahwa, Kelly E Lyons
Sep 1, 1984·British Journal of Clinical Pharmacology·H J WharradJ M Roland
Jan 25, 2020·Current Neuropharmacology·Hortensia Alonso-NavarroFélix J Jiménez-Jiménez
Nov 1, 1982·Acta Neurologica Scandinavica·T A LarsenD B Calne
Nov 30, 2000·Current Treatment Options in Neurology·D Lambert, C H Waters
Apr 15, 2003·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·D A Grimes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Related Papers

Journal of Neurology, Neurosurgery, and Psychiatry
S CalzettiA Richens
Journal of Neurology, Neurosurgery, and Psychiatry
D JeffersonC D Marsden
Journal of Neurology, Neurosurgery, and Psychiatry
L Cleeves, L J Findley
© 2021 Meta ULC. All rights reserved